Literature DB >> 23257730

High-definition optical coherence tomography for the in vivo detection of demodex mites.

T Maier1, E Sattler, M Braun-Falco, T Ruzicka, C Berking.   

Abstract

BACKGROUND: Demodex mites are involved in different skin diseases and are commonly detected by skin scrape tests or superficial biopsies. A new high-definition optical coherence tomography (HD-OCT) with high lateral and axial resolution in a horizontal (en-face) and vertical (slice) imaging mode might offer the possibility of noninvasive and fast in vivo examination of demodex mites.
METHODS: Twenty patients with demodex-related skin diseases and 20 age- and gender-matched healthy controls were examined by HD-OCT. Mites per follicle and follicles per field of view were counted and compared to skin scrape tests.
RESULTS: HD-OCT images depicted mites in the en-face mode as bright round dots in groups of 3-5 mites per hair follicle. In the patients with demodex-related disease, a mean number of 3.4 mites per follicle were detected with a mean number of 2.9 infested follicles per area of view compared to a mean of 0.6 mites in 0.4 infested follicles in the controls. The skin scrape tests were negative in 21% of the patients.
CONCLUSION: The innovative HD-OCT enables fast and noninvasive in vivo recognition of demodex mites and might become a useful tool in the diagnosis and treatment monitoring of demodex-related skin diseases.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23257730     DOI: 10.1159/000345364

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

Review 1.  [Optical coherence tomography].

Authors:  T von Braunmühl
Journal:  Hautarzt       Date:  2015-07       Impact factor: 0.751

2.  Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis.

Authors:  Tamara Quint; Patrick M Brunner; Christoph Sinz; Irene Steiner; Robin Ristl; Kornelia Vigl; Susanne Kimeswenger; Katharina Neubauer; Detlev Pirkhammer; Martin Zikeli; Wolfram Hoetzenecker; Norbert Reider; Christine Bangert
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.